Social drug use in the parturient: Implications for the management of obstetrical anaesthesia

Medical Journal of Malaysia

Volumn 58, Issue 1, 2003, Pages 147-154

  Kuczkowski, Krzystof M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Caffeine; Chemical dependency; Drug abuse; Drug addiction; Ethanol; Pregnancy; Social drug use; Tobacco

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; CAFFEINE; COCAINE; PSYCHEDELIC AGENT;

DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; HUMAN; OBSTETRIC ANESTHESIA; PREGNANCY; REVIEW; TOBACCO;

ANESTHESIA, OBSTETRICAL; CAFFEINE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; ETHANOL; FEMALE; HUMANS; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; TOBACCO;

EID: 0041520555     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Andres RL. Social and Illicit Drug Use in Pregnancy. In Creasy RK, Resnik R, eds. Maternal-Fetal Medicine. Philadelphia: W.B. Saunders Company, 1999; 145-64.
2. Kuczkowski KM. Drug Abuse in Pregnancy Anaesthetic Implications. Progress in Anaesthesiology 2001; 25: 355-72.
3. Smith CG, Asch RH. Drug abuse and reproduction. Fertil Steril 1987; 48: 355-73.
4. Bell GL, Lau K. Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am 1995; 42: 261-75.
5. Stoelting RK, Dierdorf SF. Psychiatric Illness and Substance Abuse. In Stoelting RK, Dierdorf SF, ed. Anaesthesia and Co-Existing Disease. New York: Churchill Livingstone, 1993; 517-38.
6. Kuczkowski KM, Birnbach DJ. The HIV - Infected Parturient: Is Neuraxial Anaesthesia Contraindicated? Curr Anesthesiol Rep 2000; 2: 118-21.
7. Newman LM: The Chemically Dependent Parturient. Seminars in Anaesthesia 1992; 11: 66-75.
8. Birnbach DJ. Anaesthesia and Maternal Substance Abuse. In Norris MC, ed. Obstetric Anesthesia. Philadelphia: Lippincott, 1999; 491-99.
9. Wood PR, Soni N. Anaesthesia and substance abuse. Anaesthesia 1989; 44: 672-80.
10. Bendrsky M, Alessandri S, Gilbert P, et al. Characteristics of pregnant substance abusers in two cities in the northeast. Am J Drug Alcohol Abuse 1996; 22: 349-62.
11. Slutsker L, Smith R, Higginson G et al. Recognizing illicit drug use in pregnant women: reports from Oregon birth attendants. Am J Public Health 1993; 83: 61-64.
12. Parliamentary Office of Science and Technology (1996): Common Illegal Drugs and Their Effects - Cannabis, Ecstasy, Amphetamines and LSD. London: House of Commons, 1996.
13. King JC. Substance abuse in pregnancy. A bigger problem than you think. Postgrad Med 1997; 102: 135-50.
14. Davis RB: Drug and alcohol use in the former Soviet Union: selected factors and future considerations. Intl J Addictions 1994; 29: 303-305.
15. Matera C, Warren WB, Moomjy M, et al. Prevalence of use of cocaine and other substances in an obstetric population Am J Obstet Gynecol 1990; 63: 797-801.
16. Knisely JS, Spear ER, Green DJ, et al. Substance abuse patterns in pregnant women. NIDA Res Monogr 1991; 108: 280-81.
17. Beattie C, Mark L, Umbricht-Schneiter A. Evaluation of the Patient with Alcoholism and Other Drug Dependencies. In Rogers MC, Tinker JH, Covino BG, Longnecker DE, eds. Principles and Practice of Anaesthesiology. St. Louis: Mosby, 1993; 537-59.
18. ACOG Committee Opinion: Committee of Obstetrics: Maternal and Fetal Medicine Number 114. Intl J Gynecol Obstet 1993; 41: 102-105.
19. Kuczkowski KM, Birnabach DJ, van Zundert A. Drug Abuse in the Parturient. Sem Anestesiol Periop Med and Pain 2000; 19: 3: 216-24.
20. Ebrahim SH, Luman ET, Floyd RL, et al. Alcohol consumption by pregnant women in the United States during 1988-1995. Obstet Gynecol 1998; 92: 187-92.
21. Morse RM, Flavin DK. The definition of alcoholism. JAMA 1992; 268: 1012-14.
22. Lemoine P, Harroussean H, Borteyrn JP. Les enfants de parents alcolques: Anomalies observees - A propos de 127 cases. Quest Med 1968; 25: 477-82.
23. Pietrantoni M, Knuppel RA: Alcohol use in pregnancy. Clin Perinatol 1991; 18: 93-111.
24. Pinazo-Duran MD, Renau-Piqueras J, Guerri C, et al. Optic nerve hypoplasia in fetal alcohol syndrome: an update. Eur J Opththalmol 1997; 7: 262-70.
25. Guerri C, Renau-Piqueras J. Alcohol, astroglia and brain development. Mol Neurobiol 1997; 15: 65-81.
26. Clarren SK. The diagnosis and treatment of fetal alcohol syndrome. Comp Ther 1982; 8: 41-43.
27. Council on Scientific Affairs, American Medical Association: Fetal effects of maternal alcohol abuse. JAMA 1983; 249: 2517-521.
28. Beattie MC, Longabaugh R, Elliott G, et al. Effect of the social environment on alcohol involvement and subjective well-being prior to alcoholism treatment. J Stud Alcohol 1993; 54: 283-96.
29. Sverdlov BN, Holley FO, Maitre PI. Chronic alcohol intake does not change thiopental anesthetic requirement, pharmacokinetics, or pharmacodynamics. Anaesthesiology 1990; 72: 455-61.
30. Prager K, Malin H, Spiegler D, et al. Smoking and drinking behavior before and during pregnancy of married mothers of live-born infants and stillborn infants. Publ Health Rep 1984; 99: 117-27.
31. Eriksson KM, Haug K. Salvesen KA, et al. Smoking habits among pregnant women in Norway 1994-1995. Acta Obstet Gynecol Scand 1998; 77: 159-64.
32. National Institute on Drug Abuse: National Household Survey of Drug Abuse: Population Estimates 1990 (Publication no. 91-1732). Rockville MD, Department of Health and Human Services. 1991.
33. Sprauve ME. Substance abuse and HIV in pregnancy. Clin Obstet Gynecol 1996; 39: 316-32.
34. Economides D, Braithwaite J. Smoking pregnancy and the fetus. J Royal Soc of Health 1994; 114: 198-201.
35. Rodkey FL, O'Neal JD, Collison HA. Oxygen and carbon monoxide equilibria of human adult hemoglobin at atmospheric and elevated pressure. Blood 1969; 33: 57-65.
36. Lackmann GM, Salzberger U, Tollner U, et al. Metabolites of a tobacco-specific carcinogen in urine from newborns. J Natl Cancer Inst 1999; 91: 459-65.
37. Feng T. Substance abuse in pregnancy. Curr Opin Obstet Gynecol 1993; 5: 16-23.
38. Kistin N, Handler A, Davis F, et al. Cocaine and cigarettes: a comparison of risks. Paediatr Perinatal Epidemiol 1996; 10: 269-78.
39. MacDorman, MF, Cnattingius S, Hoffman HJ, et al. Sudden infant death syndrome and smoking in the United States and Sweden. Am J Epidemiol 1997; 146: 249-57.
40. Surgeon General: The health consequences of smoking for women: A report of the Surgeon General 1983. Washington, DC, US Government Printing Office, 1983; 191-249.
41. Luciano A, Bolognani M, Biondani P, et al. The influence of maternal passive and light active smoking on intrauterine growth and body composition of the newborn. Eur J Clin Nutr 1998; 52: 760-63.
42. Van der Veen F, Fox H. The effects of cigarette smoking on the human placenta: A light and electron microscopic study. Placenta 1982; 3: 243-56.
43. Cnattingius S, Forman MR, Berendes HM, et al. Effect of age, parity and smoking on pregnancy outcome: A population based study. Am J Obstet Gynecol 1993; 168: 16-21.
44. Castles A. Adams EK, Melvin CL, et al. Effects of smoking during pregnancy. Am J Prev Med 1999; 16: 208-15.
45. Najman JM, Lanyon A, Andersen M, et al. Socioeconomic status and maternal cigarette smoking before, during and after a pregnancy. Aust N Z J Pub Health 1998; 22: 60-66.
46. American College of Obstetricians and Gynecologists: Smoking and Reproductive Health (ACOG Technical Bulletin No. 180). Washington, D.C, ACOG, 1993.
47. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking. JAMA 1999; 28: 72-76.
48. Ferry LH, Bruchette M. Efficacy of bupropion for smoking cessation in nondepressed smokers. J Addic Dis 1994; 13: 249-51.
49. Jorenby DF, Leischov SJ, Nides MA, et al. A controlled trial of sustained release bupropion and nicotine patch or both for smoking cessation. N Eng J Med 1999; 340: 685-91.
50. Pearce AC, Jones RM. Smoking and anesthesia: Preoperative abstinence and perioperative morbidity. Anaesthesiology 1984; 61: 576-84.
51. Griffiths RR. Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1999; 255: 1123-27.
52. Silverman K, Evans SM, Strain EC, et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Eng J Med 1992; 327: 1109-14.
53. Goldstein A, Warren R. Passage of caffeine into human gonadal and fetal tissue. Biochem Pharmacol 1962; 17: 166-68.
54. Soykas LF. Effects of methylxanthines on the fetus. Clin Perinatol 1979; 6: 37-51.
55. Mills JL, Holmes LB, Aarons JH, et al. Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation. JAMA 1993; 269: 593-97.
56. Oei SG, Vosters RPL, Van der Hagen NLJ. Fetal arrhythmias caused by excessive intake of caffeine by pregnant women. Br Med J 1989; 298: 568-69.
57. Fernandez O, Sbharrval M, Smiley G, et al. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. Reprod Toxicol 1998: 12: 434-444.
58. Marret S, Gressens P, Van-Maele-Fabry G, et al. Caffeine-induced disturbance of early neurogenesis in whole mouse embryo cultures. Brain Research 1997: 773: 213-216.
59. Pollard I, Murray JF, Hiller R, et al. Effects of preconceptual caffeine exposure on pregnancy and pregnancy viability. J Mater-Fet Med 1999: 8: 220-224.
60. Fennely M, Galletly DC, Purdie GI. Is caffeine withdrawal the mechanism of postoperative headache? Anesth Analg 1991: 72: 449-453.